Rupture- and Formation-Associated Molecular Concordance Between Intracranial and Abdominal Aortic Aneurysms: A Cross-Bed Transcriptomic, Genetic, and Pharmacologic Analysis
Background/Objectives: No drug prevents an intracranial aneurysm (IA) or an abdominal aortic aneurysm (AAA) from rupturing. The two diseases share molecular features, but whether that commonality lies preferentially in rupture—the transition a preventive treatment must avert—has not, to our knowledge, been addressed directly. We therefore examined whether rupture-associated transcriptional changes exhibit greater cross-bed directional concordance than formation-associated changes. Methods: Across eight human transcriptomic series, we compared cross-bed directional concordance for rupture (ruptured versus unruptured) and formation (aneurysm versus control) using a prespecified difference standardized against a signal-free joint specimen-level permutation null. Replication, co-expression organization, classifier transportability, functional enrichment, human genetic evidence, and pharmacologic tractability were examined as distinct evidence domains, supplemented by conditional simulations of signal-to-noise asymmetry and sensitivity analyses of cross-platform classifier transfer. Results: Preferentially greater rupture-associated concordance was not demonstrated: at the gene, gene-set, and program levels, all three point estimates favored formation, but none of the one-sided tests supported the prespecified rupture-favoring alternative (Holm-adjusted p = 1.0000). A reproducible rupture-associated component nonetheless remained: 459 of 1115 concordant genes measurable in all three independent IA validation cohorts retained their direction in each. Rupture-associated modules were variably preserved, and classifiers lost discrimination on transfer between IA and AAA cohorts profiled on different platforms. Only collagen-related enrichment remained significant under the measurable-gene background specification. Genetic estimates were obtainable for five of 63 prioritized genes, but none met the prespecified support criteria; documented pharmacologic actions both opposed and reinforced rupture-associated expression. Conclusions: Shared transcription, conserved organization, human genetic support, and pharmacologic direction were distinct properties of the rupture-associated signal. Preventive target selection should preserve these distinctions rather than allow cross-bed transcriptional concordance to stand in for evidence it does not provide.
Authors
- Lütfi Çağatay Onar (ORCID: https://orcid.org/0000-0002-7767-9029)
- Muharrem Furkan Yuzbasi (ORCID: https://orcid.org/0000-0002-2816-6921)
- Tamer Tamdoğan (ORCID: https://orcid.org/0000-0002-0526-1459)
- Sevim Ondul (ORCID: https://orcid.org/0000-0003-4219-4862)
- İbrahim Yılmaz (ORCID: https://orcid.org/0000-0003-2003-6337)
Institutions
- Ministry of Health (TR)
- Giresun University (TR)
- Kahramanmaraş Sütçü İmam University (TR)
Publication Details
- Journal
- Biomedicines
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3390/biomedicines14112647
- Primary Topic
- Intracranial Aneurysms: Treatment and Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00